The Harvard Drug Group is voluntarily recalling 174 cartons of Major Pharmaceuticals Paliperidone Extended-Release Tablets, 9 mg, a medication (paliperidone) used to treat schizophrenia and schizoaffective disorder. The product failed dissolution tests, meaning it may not release the active ingredient at the correct rate. No injuries or incidents have been reported to date, but the failure could impact how effectively the medication works for patients.
Failure to meet dissolution specifications can cause the medication to release either too slowly or too quickly in the body. This could lead to a lack of efficacy in treating psychiatric symptoms or cause unexpected side effects due to improper dosing rates.
You have 2 options:
Manufactured by Sun Pharmaceutical Industries Ltd. in India; Distributed by Major Pharmaceuticals.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.